Allergan's most recent trend suggests a bullish bias. One trading opportunity on Allergan is a Bull Put Spread using a strike $225.00 short put and a strike $215.00 long put offers a potential 9.65% return on risk over the next 34 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $225.00 by expiration. The full premium credit of $0.88 would be kept by the premium seller. The risk of $9.12 would be incurred if the stock dropped below the $215.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Allergan is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Allergan is bullish.
The RSI indicator is at 78.38 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Allergan
5 Things Allergan's Management Just Said That You Need to Know
Thu, 15 Jun 2017 19:42:00 +0000
Allergan executives hint at what's in store for the drugmaker at the Goldman Sachs healthcare conference.
Allergan CEO on the battle over drug pricing
Thu, 15 Jun 2017 17:38:00 +0000
CNBC's Meg Tirrell talks to Brent Saunders, Allergan CEO, about an executive order on possibly lowering drug prices live from the Heartland Health Summit.
Allergan Plc breached its 50 day moving average in a Bullish Manner : AGN-US : June 15, 2017
Thu, 15 Jun 2017 12:13:37 +0000
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Allergan Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 … Read more
Opioid Stocks Feel the Pressure of FDA Measures
Sun, 11 Jun 2017 18:27:00 +0000
Recent FDA measures to curb the alarming U.S. opioid epidemic is hurting some drug stocks.
New migraine drugs have promise — and a $8,500 price tag
Fri, 09 Jun 2017 16:02:31 +0000
They’re the first drugs developed for migraine in a long time. But migraine patients worry they won’t be able to access them.
Also on Market Tamer…
Follow Us on Facebook